Fear of covid-19 and covid-19 anxiety as predictors of adherence to treatment in patients with epilepsy
Published:
Jul 16, 2023
Keywords:
Epilepsy Coronavirus Fear Anxiety medication adherence
Abstract
Background: The study aimed to examine fear of COVID-19 and Coronavirus Anxiety as predictors of adherence to treatment in individuals diagnosed with epilepsy during the COVID-19 pandemic.
Method and Material: The study was carried out in a university hospital. The research sample consisted of 154 epilepsy patients. The patient identification form, Coronavirus (Covid-19) Fear Scale, Coronavirus Anxiety Scale, and the Medication Adherence Report Scale (MARS) were used as data collection tools. The data were shown as percentages and mean ± standard deviation (SD), and Pearson/Spearmen correlation and linear regression analyses were used to examine the relationship between the variables.
Results: The results of the analysis demonstrated that the model established for medication adherence in epilepsy patients was significant (F: 12,892, p < 0.001). In addition, for medication adherence, COVID-19 anxiety (β = -0.312), regular drug use (β = 0.242), seizure frequency (β = -0.234), and accommodation in the city center (β = -0.173) were found to be statistically significant predictors (p < 0.001). It was found that the variables explained 24% of the total variance.
Conclusions: It should be remembered that infectious diseases such as COVID-19 can reoccur and that it is necessary to be prepared for new contagious diseases likely to occur. In case of the recurrence of infectious diseases such as COVID-19, it is important to conduct interventional/experimental studies on how to increase medication adherence of patients and how to reduce COVID-19 anxiety.
Article Details
- How to Cite
-
Sungur, M., Arda Sürücü, H., Köleoğlu, Şerife, & Altay, Çimen. (2023). Fear of covid-19 and covid-19 anxiety as predictors of adherence to treatment in patients with epilepsy . Health & Research Journal, 9(3), 143–156. https://doi.org/10.12681/healthresj.33447
- Section
- Original Articles
Copyright notice:
The journal "Health and Research Journal" reserves the rights for copyright of the content of the website and also the copyright of the articles published.
By virtue of their appearance in this journal, the articles are free to be used for non-commercial purposes. However, the articles cannot and must not be used in anyway, published elsewhere or modified without any reference to the author and the first publication of the article.
Downloads
Download data is not yet available.
References
Snoeijen-Schouwenaars FM, van Ool JS, Tan IY, Aldenkamp AP, Schelhaas HJ, Hendriksen J. Mood, anxiety, and perceived quality of life in adults with epilepsy and intellectual disability. Acta neurologica Scandinavica, 2019;139(6), 519–525. https://doi.org/10.1111/ane.13085
World Health Organization. Epilepsy: A public health imperative. (2019). https://www.who.int/mental_health/neurology/epilepsy/report_2019/en/
Yel P, Karadakovan A. Epilepsi Hastalarında Tedaviye Uyum ve Etkileyen Faktörler. Ege Üniversitesi Hemşire-lik Fakültesi Dergisi, 2021;37(3), 223-238. DOI: 10.53490/egehemsire.746425
Asghar MA, Rehman AA, Raza ML, Shafiq Y, Asghar MA. Analysis of treatment adherence and cost among patients with epilepsy: a four-year retrospective cohort study in Pakistan. BMC Health Serv Res. 2021; 21(1), 72. doi:10.1186/s12913-021-06085-0
Faught E. Adherence to antiepilepsy drug therapy. Epilepsy Behav. 2012; 25(3), 297-302. doi:10.1016/j.yebeh.2012.08.027
Wilder ME, Kulie P, Jensen C, Levett P, Blanchard J, Dominguez LW, et al. The Impact of Social Determinants of Health on Medication Adherence: a Systematic Review and Meta-analysis. Journal of general internal medicine, 2021;36(5), 1359–1370. https://doi.org/10.1007/s11606-020-06447-0
Davis KL, Candrilli SD, Edin HM. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia, 2008; 49(3), 446-454. doi:10.1111/j.1528-1167.2007.01414.x
Gollwitzer S, Kostev K, Hagge M, Lang J, Graf W, Ha-mer HM. Nonadherence to antiepileptic drugs in Ger-many: A retrospective, population-based study. Neu-rology, 2016; 87(5), 466-472. doi:10.1212/WNL.0000000000002791
Van Hees S, Siewe Fodjo JN, Wijtvliet V, Van den Bergh R, Faria de Moura Villela E, da Silva CF, et al. Access to healthcare and prevalence of anxiety and depression in persons with epilepsy during the COVID-19 pandemic: A multicountry online survey. Epilepsy Behav. 2020 Nov;112:107350. doi: 10.1016/j.yebeh.2020.107350. Epub 2020 Sep 10. PMID: 32920373; PMCID: PMC7481834.
Li P, Lin J, Wu C, Huang S, Zhu S. The impact of social factors, especially psychological worries on anxiety and depression in patients with epilepsy. Epilepsy Be-hav. 2021;125:108376. doi:10.1016/j.yebeh.2021.108376
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) out-break. J Autoimmun. 2020;109:102433. doi:10.1016/j.jaut.2020.102433
Granata T, Bisulli F, Arzimanoglou A, Rocamora R. Did the COVID-19 pandemic silence the needs of people with epilepsy?. Epileptic Disord. 2020;22(4):439-442. doi:10.1684/epd.2020.1175
French JA, Brodie MJ, Caraballo R, Devinsky O, Ding D, Jehi L, et al . Keeping people with epilepsy safe during the COVID-19 pandemic. Neurology. 2020 Jun 9;94(23):1032-1037. doi: 10.1212/WNL.0000000000009632. Epub 2020 Apr 23. PMID: 32327490; PMCID: PMC7455365.
Kuroda N. Epilepsy and COVID-19: Updated evidence and narrative review. Epilepsy Behav. 2021 Mar;116:107785. doi: 10.1016/j.yebeh.2021.107785. Epub 2021 Jan 13. PMID: 33515934; PMCID: PMC7805398.
Aktar B, Balcı B, Ferik S, Öztura I, Baklan B. Physical Activity, Anxiety, and Seizure Frequency in Epilepsy: The Results of the First 3 Months of the Coronavirus Disease 2019 Pandemic. Epilepsi, 2021; 27, 85-90.
Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psy-chiatry. 2020 Mar;7(3):228-229. doi: 10.1016/S2215-0366(20)30046-8. Epub 2020 Feb 4. PMID: 32032543; PMCID: PMC7128153.
Koh MY, Lim KS, Fong SL, Khor SB, Tan CT. Impact of COVID-19 on quality of life in people with epilepsy, and a multinational comparison of clinical and psychological impacts. Epilepsy Behav. 2021 Apr;117:107849. doi: 10.1016/j.yebeh.2021.107849. Epub 2021 Feb 10. PMID: 33631434; PMCID: PMC8021335.
Aledo-Serrano Á, Mingorance A, Jiménez-Huete A, Toledano R, García-Morales I, Anciones C, et al. Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective. Epilepsia. 2020 Jun;61(6):1312-1314. doi: 10.1111/epi.16537. Epub 2020 May 18. PMID: 32420620; PMCID: PMC7276740.
Erdfelder E, Faul F, Buchner A. GPOWER: A general power analysis program. Behavior research methods, instruments, & computers, 1996;28(1), 1-11.
d'Orsi G, Mazzeo F, Ravidà D, Di Claudio MT, Sabetta A, Lalla A, et al. The effect of quarantine due to Covid-19 pandemic on seizure frequency in 102 adult people with epilepsy from Apulia and Basilicata regions, Southern Italy. Clin Neurol Neurosurg. 2021 Apr;203:106592. doi: 10.1016/j.clineuro.2021.106592. Epub 2021 Mar 2. PMID: 33684674.
Alkhotani A, Siddiqui MI, Almuntashri F, Baothman R. The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy. Epilepsy Behav. 2020 Nov;112:107323. doi: 10.1016/j.yebeh.2020.107323. Epub 2020 Jul 14. PMID: 32712565; PMCID: PMC7359799.
Taylor S. The psychology of pandemics: Preparing for the next global outbreak of infectious disease. Cambridge Scholars Publishing. 2019
Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2022;20(3):1537-1545. doi: 10.1007/s11469-020-00270-8. Epub 2020 Mar 27. PMID: 32226353; PMCID: PMC7100496.
Bakioğlu F, Korkmaz O, Ercan H. Fear of COVID-19 and Positivity: Mediating Role of Intolerance of Uncertain-ty, Depression, Anxiety, and Stress. Int J Ment Health Addict. 2021;19(6), 2369-2382. doi:10.1007/s11469-020-00331-y
Pappas G, Kiriaze IJ, Giannakis P, Falagas ME. Psychosocial consequences of infectious diseases. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009; 15(8), 743–747.
Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Studies, 2020;44(7), 393–401. https://doi.org/10.1080/07481187.2020.174848116
Evren C, Evren B, Dalbudak E, Topcu M, Kutlu N. Measuring anxiety related to COVID-19: A Turkish validation study of the Coronavirus Anxiety Scale. Death studies, 2022;46(5), 1052–1058. https://doi.org/10.1080/07481187.2020.1774969
Gul ZB, Atakli HD. Effect of the COVID-19 pandemic on drug compliance and stigmatization in patients with epilepsy. Epilepsy Behav. 2021 Jan;114(Pt A):107610. doi: 10.1016/j.yebeh.2020.107610. Epub 2020 Nov 24. PMID: 33243679; PMCID: PMC7685058.
Horne R, Hankins M. The Medication Adherence report Scale (MARS), 2001 (manuscript submitted for publication)
Temeloğlu Şen E, Sertel Berk Ö, Sindel D. İlaç Uyumunu Bildirim Ölçeği’nin Türkçe Uyarlamasının Geçerlik ve Güvenirlik Çalışması. Journal of Istanbul Faculty of Medicine, 2019;82 (1), 52-61. DOI: 10.26650/IUITFD.413637
Junaid Farrukh M, Makmor Bakry M, Hatah E, Hui Jan T. Medication adherence status among patients with neurological conditions and its association with quality of life. Saudi Pharm J. 2021 May;29(5):427-433. doi: 10.1016/j.jsps.2021.04.003. Epub 2021 Apr 17. PMID: 34135668; PMCID: PMC8180465.
Özcan A, Avcı İA. The influence of the pandemic on fear of contagion, blood pressure management and adherence to medication in hypertensive older adults in Turkey. J Hum Hypertens. 2022 Sep;36(9):852-859. doi: 10.1038/s41371-022-00726-5. Epub 2022 Jul 18. PMID: 35851326; PMCID: PMC9289934.
Yeni K, Tulek Z, Ozer A, Cavusoglu A, Inan GS, Baykan B, Bebek N. The effect of fear of COVID-19 on quality of life in patients with epilepsy. Neurology Asia, 2022; 27(1).
Kaya S, Uzdil Z, Cakiroğlu FP. Evaluation of the effects of fear and anxiety on nutrition during the COVID-19 pandemic in Turkey. Public Health Nutr. 2021 Feb;24(2):282-289. doi: 10.1017/S1368980020003845. Epub 2020 Sep 25. PMID: 32972485; PMCID: PMC7642959.
Güçlü Altun İ, Koç G, Özen Barut B, Gökçil Z. Evaluation of the Seizure Frequency and Severity in Patients with Epilepsy Who Had COVID-19. Epilepsy, 2021;27, 163-170.
Zeng C, Meng H, Zhu Y, Yao L, Lian Y, Zhu Y, et al, Long L. Correlation of Seizure Increase and COVID-19 Outbreak in Adult Patients with Epilepsy: Findings and Suggestions from a Nationwide Multi-centre Survey in China. Seizure. 2021 May;88:102-108. doi: 10.1016/j.seizure.2021.03.029. Epub 2021 Mar 31. PMID: 33839561; PMCID: PMC9056154.
Hao X, Zhou D, Li Z, Zeng G, Hao N, Li E, et al. Severe psychological distress among patients with epilepsy during the COVID-19 outbreak in southwest China. Epilepsia. 2020 Jun;61(6):1166-1173. doi: 10.1111/epi.16544. Epub 2020 May 22. PMID: 32353184; PMCID: PMC7267575.
Xiao Z, Ding D, Li S, Hong Z. Management of people with epilepsy during the COVID-19 pandemic: a national survey among epileptologists in China. Acta Epileptologica, 2020;2(1), 19. https://doi.org/10.1186/s42494-020-00030-0
Lai SL, Hsu MT, Chen SS. The impact of SARS on epilepsy: the experience of drug withdrawal in epileptic patients. Seizure. 2005 Dec;14(8):557-61. doi: 10.1016/j.seizure.2005.08.010. Epub 2005 Sep 26. PMID: 16188463; PMCID: PMC7111166.
Assenza G, Lanzone J, Brigo F, Coppola A, Di Gennaro G, Di Lazzaro V, et al. Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening. Front Neurol. 2020 Jul 3;11:737. doi: 10.3389/fneur.2020.00737. PMID: 32719655; PMCID: PMC7350269.
Eren F, Gül G. Epilepsili Hastalarda COVID-19 Salgının Yaşam Kalitesi, Nöbet Sıklığı, Depresyon ve Anksiyete Üzerindeki Etkisi: Erken Dönemde Kesitsel Bir Çalışma. Epilepsi, 2021;27, 212-220.
Pham ST, Dam CV, Duong CX, Duong NHP, Nguyen XTK, Diep HG, Nguyen NK, Le DTN, Nguyen TTN, Le TTC, Nguyen TTT, Asten HV, Nguyen T. Medication Adherence of Vietnamese Outpatients with Chronic Diseases during the COVID-19 Pandemic. Trop Med Infect Dis. 2022 Jun 13;7(6):101. doi: 10.3390/tropicalmed7060101. PMID: 35736980; PMCID: PMC9228239.
Nguyen NK, Diep HG, Ly HHV, Nguyen NLM, Taxis K, Pham ST, Vo TH, Nguyen T. Medication Adherence and Belief about Medication among Vietnamese Patients with Chronic Cardiovascular Diseases within the Context of Implementing Measures to Prevent COVID-19. J Cardiovasc Dev Dis. 2022 Jun 26;9(7):202. doi: 10.3390/jcdd9070202. PMID: 35877564; PMCID: PMC9324658.
Ryu JE, Kang SG, Jung SH, Lee SH, Kang SB. Psychological Effects and Medication Adherence among Korean Patients with Inflammatory Bowel Disease during the Coronavirus Disease 2019 Pandemic: A Single-Center Survey. J Clin Med. 2022 May 27;11(11):3034. doi: 10.3390/jcm11113034. PMID: 35683421; PMCID: PMC9181113.
Zhang Y, Wang S, Ding W, Meng Y, Hu H, Liu Z, et al. Status and influential factors of anxiety depression and insomnia symptoms in the work resumption period of COVID-19 epidemic: A multicenter cross-sectional study. J Psychosom Res. 2020 Nov;138:110253. doi: 10.1016/j.jpsychores.2020.110253. Epub 2020 Sep 18. PMID: 32979696; PMCID: PMC7500335.
Yeni K, Tulek Z, Bebek N, Dede O, Gurses C, Baykan B, et al. Attitudes towards epilepsy among a sample of Turkish patients with epilepsy. Epilepsy & behavior: E&B, 2016; 62, 66–71. https://doi.org/10.1016/j.yebeh.2016.06.022
Türktemiz H, Özgün Ü. COVID-19 Korkusunun Aşı Tutumuna Etkisinde Bilgi Arama Davranışının ve Aşı Bilgisi İnancının Aracı Rolü. Balıkesir Sağlık Bilimleri Dergisi, 2021;10(3), 367-378.
